Skip to main content
Top
Published in: Rheumatology International 4/2010

01-02-2010 | Letter to the Editor

Proteomics analysis in 28 patients with systemic IgG4-related plasmacytic syndrome

Authors: Motohisa Yamamoto, Yasuyoshi Naishiro, Chisako Suzuki, Yasuo Kokai, Ryo Suzuki, Saho Honda, Takashi Abe, Hiroki Takahashi, Yasuhisa Shinomura

Published in: Rheumatology International | Issue 4/2010

Login to get access

Abstract

It is considered that autoimmune pancreatitis (AIP), Mikulicz’s disease (MD) and IgG4-related tubulointerstitial nephritis (TIN) comprise systemic IgG4-related plasmacytic syndrome (SIPS), of which the origin remains unknown. We analyzed these patients with focus on serological aspects to invest whether there are autoantigens in SIPS. We evaluated 28 patients with SIPS who presented at Sapporo Medical University Hospital and the collaborated institutions. They were mainly middle-aged (eight male), and consisted of 26 patients with MD and two patients with AIP. The three among 26 patients diagnosed with MD were complicated to AIP, and another three patients had IgG4-related TIN. As a control, healthy volunteers and the patients with Sjögren’s syndrome were examined. At first, we measured the levels of serum complements and circulating immune complexes in these patients. Next, immune complexes were collected from the serum of patients and healthy controls by immunoprecipitation. They were divided into immunoglobulin and the antigens by glycine–HCl solution. The divided samples including the antigens were analyzed by surface-enhanced laser desorption/ionization-time of flight-mass spectrometry (SELDI-TOF-MS). Nine patients had hypocomplementemia and 15 had elevated levels of circulating immune complexes in the group of SIPS. In the groups of healthy volunteers and SS, all showed that the levels of serum complements and circulating immune complexes were normal. SELDI-TOF-MS detected a 13.1-kDa protein from all samples of SIPS, and not in normal control and SS. It is possible that the 13.1-kDa protein is one of the autoantigens of SIPS.
Literature
3.
go back to reference Takato H, Yasui M, Ichikawa Y, Fujiyama M, Nakao S, Zen Y et al (2008) Nonspecific interstitial pneumonia with abundant IgG4-positive cells infiltration, which was thought as pulmonary involvement of IgG4-related autoimmune disease. Intern Med 47:291–294. doi:10.2169/internalmedicine.47.0411 CrossRefPubMed Takato H, Yasui M, Ichikawa Y, Fujiyama M, Nakao S, Zen Y et al (2008) Nonspecific interstitial pneumonia with abundant IgG4-positive cells infiltration, which was thought as pulmonary involvement of IgG4-related autoimmune disease. Intern Med 47:291–294. doi:10.​2169/​internalmedicine​.​47.​0411 CrossRefPubMed
5.
go back to reference Yamamoto M, Harada S, Ohara M, Suzuki C, Naishiro Y, Yamamoto H et al (2005) Clinical and pathological differences between Mikulicz’s disease and Sjögren’s syndrome. Rheumatology (Oxford) 44:227–234. doi:10.1093/rheumatology/keh447 CrossRef Yamamoto M, Harada S, Ohara M, Suzuki C, Naishiro Y, Yamamoto H et al (2005) Clinical and pathological differences between Mikulicz’s disease and Sjögren’s syndrome. Rheumatology (Oxford) 44:227–234. doi:10.​1093/​rheumatology/​keh447 CrossRef
6.
go back to reference Morgan WS, Castleman B (1953) A clinicopathologic study of “Mikulicz’s disease”. Am J Pathol 29:471–503PubMed Morgan WS, Castleman B (1953) A clinicopathologic study of “Mikulicz’s disease”. Am J Pathol 29:471–503PubMed
7.
go back to reference Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE et al (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554–558. doi:10.1136/ard.61.6.554 CrossRefPubMed Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE et al (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554–558. doi:10.​1136/​ard.​61.​6.​554 CrossRefPubMed
8.
go back to reference Mayer MM (1961) Complement and complement fixation. In: Kabat E, Mayer MM (eds) Experimental immunochemistry III. Thomas Springfield, IL, pp 133–240 Mayer MM (1961) Complement and complement fixation. In: Kabat E, Mayer MM (eds) Experimental immunochemistry III. Thomas Springfield, IL, pp 133–240
11.
go back to reference Liu XP, Shen J, Li ZF, Yan L, Gu J (2006) A serum proteomic patterns for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry. Cancer Invest 24:747–753. doi:10.1080/07357900601063873 CrossRefPubMed Liu XP, Shen J, Li ZF, Yan L, Gu J (2006) A serum proteomic patterns for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry. Cancer Invest 24:747–753. doi:10.​1080/​0735790060106387​3 CrossRefPubMed
12.
go back to reference Matsuo K, Xiang Y, Nakamura H, Masuko K, Yudoh K, Noyori K et al (2006) Identification of novel citrullinated autoantigens of synovium in rheumatoid arthritis using a proteomic approach. Arthritis Res Ther 8:R175. doi:10.1186/ar2085 CrossRefPubMed Matsuo K, Xiang Y, Nakamura H, Masuko K, Yudoh K, Noyori K et al (2006) Identification of novel citrullinated autoantigens of synovium in rheumatoid arthritis using a proteomic approach. Arthritis Res Ther 8:R175. doi:10.​1186/​ar2085 CrossRefPubMed
13.
go back to reference Kimura A, Sakurai T, Tanaka Y, Hozumi I, Takahashi K, Takemura M et al (2008) Proteomic analysis of autoantibodies in neuropsychiatric systemic lupus erythematosus patient with white matter hyperintensities on brain MRI. Lupus 17:16–20. doi:10.1177/0961203307085112 CrossRefPubMed Kimura A, Sakurai T, Tanaka Y, Hozumi I, Takahashi K, Takemura M et al (2008) Proteomic analysis of autoantibodies in neuropsychiatric systemic lupus erythematosus patient with white matter hyperintensities on brain MRI. Lupus 17:16–20. doi:10.​1177/​0961203307085112​ CrossRefPubMed
14.
go back to reference Okunuki Y, Usui Y, Takeuchi M, Kezuka T, Hattori T, Masuko K et al (2007) Proteomic surveillance of autoimmunity in Behçet’s disease with uveitis: selenium binding protein is a novel autoantigen in Behçet’s disease. Exp Eye Res 84:823–831. doi:10.1016/j.exer.2007.01.003 CrossRefPubMed Okunuki Y, Usui Y, Takeuchi M, Kezuka T, Hattori T, Masuko K et al (2007) Proteomic surveillance of autoimmunity in Behçet’s disease with uveitis: selenium binding protein is a novel autoantigen in Behçet’s disease. Exp Eye Res 84:823–831. doi:10.​1016/​j.​exer.​2007.​01.​003 CrossRefPubMed
Metadata
Title
Proteomics analysis in 28 patients with systemic IgG4-related plasmacytic syndrome
Authors
Motohisa Yamamoto
Yasuyoshi Naishiro
Chisako Suzuki
Yasuo Kokai
Ryo Suzuki
Saho Honda
Takashi Abe
Hiroki Takahashi
Yasuhisa Shinomura
Publication date
01-02-2010
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 4/2010
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-009-1030-4

Other articles of this Issue 4/2010

Rheumatology International 4/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine